Viatris (VTRS) Other Non Operating Income (2019 - 2026)
Viatris (VTRS) recorded quarterly Other Non Operating Income of -$47.5 million in Q1 2026, down 54.72% quarter-over-quarter from -$30.7 million in Q4 2025, and up 52.17% on a YoY basis from -$31.2 million in Q1 2025.
Viatris (VTRS) Other Non Operating Income (2019 - 2026) Analysis & Trends
Viatris' Other Non Operating Income history runs 8 years deep, the most recent figure standing at -$47.5 million for Q1 2026.
- In Q1 2026, Other Non Operating Income rose 52.17% year-over-year to -$47.5 million; the TTM figure through Mar 2026 stood at -$478.8 million (down 421.57% YoY), while the FY2025 annual figure was -$530.6 million, down 536.97% from the prior year.
- Other Non Operating Income was -$47.5 million for Q1 2026 at Viatris, down from -$30.7 million in the prior quarter.
- In the past five years, Other Non Operating Income ranged from a high of $1.8 billion in Q4 2022 to a low of -$333.5 million in Q2 2025.
- Historically, Other Non Operating Income has averaged $80.5 million across 5 years, with a median of -$6.1 million in 2024.
- The sharpest annual moves came in 2022 and 2025: Other Non Operating Income soared 8198.17% in 2022, then sank 5367.21% in 2025.
- A 5-year view of Other Non Operating Income shows it stood at $1.8 billion in 2022, then tumbled by 114.28% to -$259.6 million in 2023, then surged by 101.31% to $3.4 million in 2024, then sank by 1002.94% to -$30.7 million in 2025, then slumped by 54.72% to -$47.5 million in 2026.
- The last three Other Non Operating Income figures came in at -$47.5 million (Q1 2026), -$30.7 million (Q4 2025), and -$67.1 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn |
| 10 | Viatris | - | - | 1.16 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -47.50 Mn |
| Dec 31, 2025 | -30.70 Mn |
| Sep 30, 2025 | -67.10 Mn |
| Jun 30, 2025 | -333.50 Mn |
| Mar 31, 2025 | -99.30 Mn |
| Dec 31, 2024 | 3.40 Mn |
| Sep 30, 2024 | 10.20 Mn |
| Jun 30, 2024 | -6.10 Mn |
| Mar 31, 2024 | 139.10 Mn |
| Dec 31, 2023 | -259.60 Mn |
| Sep 30, 2023 | 92.00 Mn |
| Jun 30, 2023 | 107.50 Mn |
| Mar 31, 2023 | 69.90 Mn |
| Dec 31, 2022 | 1.82 Bn |
| Sep 30, 2022 | 20.60 Mn |
| Jun 30, 2022 | -13.50 Mn |
| Mar 31, 2022 | -33.70 Mn |
| Dec 31, 2021 | 21.90 Mn |
| Sep 30, 2021 | -5.80 Mn |
| Jun 30, 2021 | -4.20 Mn |